Afuco™ Anti-Human IL2RB ADCC Therapeutic Antibody (MiK-Beta-1), ADCC Enhanced
Anti-IL2RB ADCC Enhanced Antibody (MiK-Beta-1) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC. The humanized Mik beta 1 in combination with humanized anti-Tac will provide a new immunosuppressive therapy for the treatment of autoimmune diseases, graft-versus-host disease, and prevention of allograft rejection.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-408CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | IL2RB |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |